Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-002554

Options or other derivatives

  • PRESIDENT AND CEO acquired 992,409 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Aggarwal Sumit · PRESIDENT AND CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-18 Grant or award : show line 1 in the form Stock Options (Right to Buy) +992,409 992,409 D
Loading xslF345X03/form4-05182021_050501.xml…